| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 20.11 M USD | 8.43 M USD | -12.50 M USD | -8.49 M USD | -4.59 M USD | 6.64 M USD | 1.21 M USD | 2.35 M USD | 605122 USD | -4.33 M USD | -4.97 M USD | -3.16 M USD |
| Depreciation & Amortization | 2.25 M USD | 5.16 M USD | 7.11 M USD | 6.78 M USD | 4.66 M USD | 2.04 M USD | 718000 USD | 338000 USD | 338682 USD | 368102 USD | 343218 USD | 258119 USD |
| Stock-Based Compensation | 22.99 M USD | 30.92 M USD | 31.67 M USD | 25.33 M USD | 13.96 M USD | 5.98 M USD | 3.04 M USD | 1.52 M USD | 1.27 M USD | 776994 USD | 511457 USD | 229679 USD |
| Capital Expenditures | 9.48 M USD | 3.23 M USD | 6.38 M USD | 10.38 M USD | 8.38 M USD | 1.96 M USD | 675000 USD | 500000 USD | 143767 USD | 143533 USD | 134012 USD | 589680 USD |
| Cash Flow from Investing | -71.54 M USD | 58.30 M USD | 17.84 M USD | -58.12 M USD | -13.19 M USD | -24.71 M USD | -27.02 M USD | -6.50 M USD | -143767 USD | 392792 USD | 4.24 M USD | -8.14 M USD |
| Cash Flow from Financing | -10.92 M USD | -6.78 M USD | 10.59 M USD | 16.32 M USD | -2.78 M USD | 102.08 M USD | 1.60 M USD | 28.15 M USD | 4.80 M USD | 3.17 M USD | 368753 USD | 13.68 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 10.64 M USD | 5.20 M USD | -18.88 M USD | -18.87 M USD | -12.98 M USD | 4.68 M USD | 538000 USD | 1.85 M USD | 461355 USD | -4.47 M USD | -5.11 M USD | -3.75 M USD |
Biolife Solutions Inc. is a leading provider of cell and gene therapy bioproduction tools and services. It specializes in offering biopreservation media, automated thawing devices, and storage solutions that are essential for preserving and transporting biological materials. The company's products help enhance the quality and stability of biological samples, which is crucial in sectors like regenerative medicine, biobanking, and drug discovery. By ensuring the safe handling and preservation of cells, tissues, and organs, Biolife Solutions plays a pivotal role in supporting life science research and clinical applications. The company's innovations contribute significantly to advancing therapeutic research and the development of treatments, thereby impacting the healthcare industry extensively. Headquartered in Bothell, Washington, Biolife Solutions Inc. is strategically positioned in the market, facilitating the evolving needs of the biopharmaceutical sector worldwide.